When estrogen sparks clotting: the lactoferrin-FXI link

Key Points

• To explore the relationship between estrogen and clotting through the lactoferrin-FXI pathway.
• Analyzed markers of inflammation including plasma IFN- and CCL2 levels.
• Investigated correlations between uACR and clotting factors in patients.
• Performed statistical analyses to determine significance of findings.
• Identified significant associations between elevated markers and clotting.
• Found that abnormal uACR may reflect systemic inflammation.
• Concluded that estrogen could trigger clotting mechanisms through lactoferrin-FXI link.